loading page

Molecular pathology and clinical treatment of primary serous carcinoma of the uterine cervix: A case report
  • +9
  • Lina Niu,
  • Fangying Ruan,
  • Qisheng Yang,
  • Chaoran Xia,
  • Bifeng Zhang,
  • Tao Xu,
  • Fei Dong,
  • Lizhen Zhang,
  • Sheng Guo,
  • Weiqin Lv,
  • Junxia Wang,
  • Yun Shang
Lina Niu
Yuncheng Central Hospital

Corresponding Author:[email protected]

Author Profile
Fangying Ruan
Zhejiang Shaoxing Topgen Biomedical Technology CO.,LTD.
Author Profile
Qisheng Yang
Zhejiang Shaoxing Topgen Biomedical Technology CO.,LTD.
Author Profile
Chaoran Xia
Yuncheng Central Hospital
Author Profile
Bifeng Zhang
Zhejiang Shaoxing Topgen Biomedical Technology CO.,LTD.
Author Profile
Tao Xu
Yuncheng Central Hospital
Author Profile
Fei Dong
Yuncheng Central Hospital
Author Profile
Lizhen Zhang
Yuncheng Central Hospital
Author Profile
Sheng Guo
Yuncheng Central Hospital
Author Profile
Weiqin Lv
Yuncheng Central Hospital
Author Profile
Junxia Wang
Yuncheng Central Hospital
Author Profile
Yun Shang
Yuncheng Central Hospital
Author Profile

Abstract

A 69 years old Chinese female patient presented with independent HPV serous carcinoma uterine cervix. The genetic testing identified gene variants of PAX8 and TP53, microsatellite instability stable, TMB 7.33Muts/Mb. The patient had a good response to Docetaxel, carboplatin, and radiation with 18 months of free disease survival.
16 Nov 2022Submitted to Clinical Case Reports
16 Nov 2022Submission Checks Completed
16 Nov 2022Assigned to Editor
30 Dec 2022Reviewer(s) Assigned
06 Jan 2023Review(s) Completed, Editorial Evaluation Pending
02 May 2023Editorial Decision: Revise Minor
05 Jul 20231st Revision Received
06 Jul 2023Submission Checks Completed
06 Jul 2023Assigned to Editor
06 Jul 2023Review(s) Completed, Editorial Evaluation Pending
01 Aug 2023Editorial Decision: Accept